// App-Quantinova.ai

TCT-204 : Optimal duration of dual antiplatelet therapy (DAPT) after second generation drug-eluting stent (DES) implantation in elderly patients: the SECURITY-ELDERLY substudy

Researchers

Presenter

  • Luca Angelo Ferri

Principal Investigators

  • Alaide Chieffo

  • Gennaro Giustino

  • Arian Frasheri

  • Roberto Garbo

  • Monica Masotti-Centol

  • Neus Salvatella

  • Juan Francisco Oteo Dominguez

  • Luigi Steffanon

  • Giuseppe Tarantini

Medical Centers

  • S Antonio Abate Hospital, Trapani, Italy

  • Interventional Cardiology Institute San Raffaele Hospital, Milan, Italy

  • Hospital Puerta de Hierro, Madrid, Spain

  • Policlinico Umberto I University, Rome, Italy

  • Azienda Ospedaliero-Universitaria, Udine, Italy

  • Istituto Clinico Humanitas IRCCS, Rozzano (Milan), Italy

  • Torino, Italy

  • Madrid, Spain

  • Bellaria Maggiore Hospital, Bologna, Italy

  • University of Padova, Department of Cardiac, Thoracic and Vascular Sciences, Padova, Italy

  • Icahn School of Medicine at Mount Sinai, New York, New York, United States

Locations

  • United States

  • Spain

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved